<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=138728"><dc:title>DNA-encoded library screening on two validated enzymes of the peptidoglycan biosynthetic pathway</dc:title><dc:creator>Proj,	Matic	(Avtor)
	</dc:creator><dc:creator>Bozovičar,	Krištof	(Avtor)
	</dc:creator><dc:creator>Hrast Rambaher,	Martina	(Avtor)
	</dc:creator><dc:creator>Frlan,	Rok	(Avtor)
	</dc:creator><dc:creator>Gobec,	Stanislav	(Avtor)
	</dc:creator><dc:subject>antibacterial agents</dc:subject><dc:subject>DNA-encoded library</dc:subject><dc:subject>screening</dc:subject><dc:subject>inhibitors</dc:subject><dc:description>Screening of DNA-encoded libraries is an emerging technology for discovering hits against protein targets. With the recent launch of the DELopen platform, a facile screening of 4.4 billion compounds is available to accelerate the drug discovery process. Here we report an affinity-based screening of the DELopen library for the first time. The screening was performed against two bacterial enzymes of the peptidoglycan biosynthetic pathway, N-acetylglucosamine-enolpyruvyl transferase (MurA) and D-alanine:D-alanine ligase (DdlB). Several binders were obtained and selected for off-DNA synthesis. Hits with confirmed inhibitory potency were deconstructed into smaller fragments. In this way, two new MurA inhibitors with antibacterial activity were obtained and are available for further optimization.</dc:description><dc:date>2022</dc:date><dc:date>2022-08-11 07:11:34</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>138728</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
